ALL - Here's a piece from today that everyone seems to be overlooking. Please note the section that says: The SEC's letter stated
that the request "should not be construed as an adverse reflection on
any person, security, issuer, or transaction."
Funny how this made it across Bloomberg but never hit the more widely used Dow Jones News Retrieval.
Josh
(c) 1997 Business Wire | www.businesswire.com>
BW0128 JAN 31,1997 11:52 PACIFIC 14:52 EASTERN
( BW)(RADISYS)(RSYS) RADISYS ASSERTS NO SUBSTANCE TO LAWSUIT;
RadiSys Volunteers Cooperation with SEC
Business Editors
HILLSBORO, Ore.--(BUSINESS WIRE)--Jan. 31, 1997--In response to
inquiries, RadiSys Corp. (NASDAQ: RSYS) reasserted today that there
is no substance to the allegations of financial discrepancies that
were made by a former employee in a wrongful termination lawsuit
filed in July 1996.
The company reported that the litigation is currently in the
discovery phase, with certain documentation having been exchanged and
depositions scheduled to continue into February.
In connection with this lawsuit, in November 1996 RadiSys
received some inquiries regarding this lawsuit and whether it had
been contacted by the SEC. At that time, RadiSys had not been
contacted by the SEC. Subsequently, RadiSys contacted the SEC and
volunteered its full cooperation.
RadiSys reported yesterday that the SEC later asked RadiSys to
voluntarily provide the SEC with supporting documentation for its
financial statements and certain additional information related to
the allegations in the litigation. The company promptly provided the
SEC with all of the requested documents. The SEC's letter stated
that the request "should not be construed as an adverse reflection on
any person, security, issuer, or transaction." The company has not
been contacted by the SEC since complying with its request and
intends to cooperate fully with any inquiry from the SEC in the
future.
RadiSys is the leading independent supplier of embedded computer
technologies used by OEMs in manufacturing automation,
telecommunications, medical equipment, transportation, test and
measurement, and retail/office automation applications.
-0-
For more information, contact RadiSys at
investor.relations@radisys.com or World Wide Web Page:
radisys.com or call the RadiSys Investor Relations Line at
503-615-RSYS.
--30--DS/se*
CONTACT: RadiSys Corp.
Brian V. Turner, 503/615-1100
brian.turner@radisys.com
KEYWORD: OREGON
INDUSTRY KEYWORD: COMPUTERS/ELECTRONICS COMED MEDICINE
REPEATS: New York 212-752-9600 or 800-221-2462; Boston 617-236-4266 or
800-225-2030; SF 415-986-4422 or 800-227-0845; LA 310-820-9473
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com |
